In SpA patients, serum VEGF levels correlated with disease activity indices as defined by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), erythrocyte sedimentation rate, or C-reactive protein (CRP). This evidence concerns the gene VEGFA and ankylosing spondylitis.